Schulman K A, Glick H A, Yabroff K R, Eisenberg J M
Department of Medicine, Georgetown University Medical Center, Washington, DC 20007, USA.
J Natl Cancer Inst Monogr. 1995(19):1-9.
Recent changes in the health care environment have led to the assessment of the costs and benefits of cancer treatment as criteria for the evaluation of new cancer therapies. The methodological framework for these assessments is provided by the field of clinical economics, a discipline that combines the techniques from clinical medicine, economics, epidemiology, and biostatistics. This article reviews the concepts of clinical economics and issues related to economic analysis of new therapies. This type of information is increasingly important to patients, clinicians, and health policy decision makers to help assure patients' access to effective cancer therapies.
近期医疗保健环境的变化促使人们将癌症治疗的成本和效益评估作为评估新癌症疗法的标准。临床经济学领域为这些评估提供了方法框架，这是一门将临床医学、经济学、流行病学和生物统计学技术相结合的学科。本文回顾了临床经济学的概念以及与新疗法经济分析相关的问题。这类信息对于患者、临床医生和卫生政策决策者来说越来越重要，有助于确保患者能够获得有效的癌症治疗方法。
